Effect of febuxostat on the endothelial dysfunction in hemodialysis patients: a randomized, placebo-controlled, double-blinded study M Alshahawey, SM Shahin, TW Elsaid, NA Sabri American Journal of Nephrology 45 (5), 452-459, 2017 | 32 | 2017 |
Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; the need for genetic implementation M Alshahawey, M Raslan, N Sabri Current research in translational medicine 68 (4), 149, 2020 | 27 | 2020 |
A genetic insight into vitamin D binding protein and COVID-19 M Alshahawey Medical Hypotheses 149, 110531, 2021 | 21 | 2021 |
Effect of febuxostat on oxidative stress in hemodialysis patients with endothelial dysfunction: A randomized, placebo-controlled, double-blinded study M Alshahawey, SM Shaheen, T Elsaid, NA Sabri International Urology and Nephrology 51, 1649-1657, 2019 | 18 | 2019 |
The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study M Alshahawey, R Elborolossy, L El Wakeel, T Elsaid, NA Sabri Nutrition, Metabolism and Cardiovascular Diseases 31 (2), 626-633, 2021 | 17 | 2021 |
New insights on mucormycosis and its association with the COVID-19 pandemic ME Mona Alshahawey, Ghadir Elhossainey, Noha Salah, Lamia Elwakeel, Khaled ... Future Science OA, 18, 2021 | 14* | 2021 |
COVID-19 and Vitamin D deficiency; the two pandemics. Are they correlated M Alshahawey Int J Vitam Nutr Res 91 (5-6), 383-384, 2021 | 9 | 2021 |
Does human leukocyte antigen gene polymorphism affect management of COVID-19 Patients MA Raslan, M Alshahawey, EM Shehata, NA Sabri A review article. Scientific J Genet Gene Ther 6 (1), 001-003, 2020 | 6 | 2020 |
Management protocols for COVID-19: Will it include targeting ADAM 17 NA Sabri, MA Raslan, M Alshahawey, E Shehata Allied J Med Res 2020; 4 (1): 5-54. 54 Allied J Med Res 2020 Volume 4 …, 2020 | 2 | 2020 |
COVID-19 and Antiviral Therapies in Cancer Patients-will it Make Difference M Alshahawey, MA Raslan, NA Sabri Ann Hematol Oncol Res 1 (2), 1008, 2020 | 2 | 2020 |
Characterizing apparent treatment resistant hypertension in the United States: insights from the All of Us Research Program M Alshahawey, E Jafari, SM Smith, CW McDonough Journal of the American Medical Informatics Association 31 (12), 2899-2907, 2024 | 1 | 2024 |
Association of COVID-19 with genotyping ApoEe4 and APOBEC3B NA Sabri, MA Raslan, M Alshahawey Allied J Med Res 2020; 4 (1):- 6. 6 Allied J Med Res 2020 Volume 4 …, 2020 | 1 | 2020 |
Cost-effectiveness analysis of denosumab versus alendronate for improving bone mineral density in renal transplant recipients: a comparative study M Alshahawey, MA Shawki, SA Sayed, A Elseasi, L ElWakeel Future Journal of Pharmaceutical Sciences 10 (1), 146, 2024 | | 2024 |
Cholecalciferol effect on oxidative stress and novel predictors of inflammation in hemodialysis patients: a prospective randomized trial M Alshahawey, LM El Wakeel, TW Elsaid, NA Sabri, RM Elborolossy Future Journal of Pharmaceutical Sciences 10 (1), 121, 2024 | | 2024 |
Optimal hyperglycemia thresholds in patients undergoing chemotherapy: a cross sectional study of oncologists’ practices TM Salgado, PB Birari, M Alshahawey, E Hickey Zacholski, E Mackler, ... Supportive Care in Cancer 32 (8), 563, 2024 | | 2024 |
Cost-effectiveness analysis of once-weekly semaglutide vs. once-daily liraglutide administered subcutaneously in patients with overweight and obesity: a decision analysis. M Alshahawey, M Ghazy, M El Morshedy, NO El Said European Review for Medical & Pharmacological Sciences 28 (9), 2024 | | 2024 |
# 3706 EFFECT OF CHOLECALCIFEROL INTAKE ON NOVEL INFLAMMATORY INDICATORS IN HEMODIALYSIS PATIENTS MA Ghazy, L Elwakeel, N Sabri, TE Said, R Maher Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063c_3706, 2023 | | 2023 |
The use of Nicotinamide in Parkinson’s disease; A Possible path to the future. Review Article SF Fahmy, M Alshahawy, N Mohamed, N Gamal, S Abdelazim, ... Archives of Pharmaceutical Sciences Ain Shams University 7 (1), 147-170, 2023 | | 2023 |
WEEKLY VERSUS MONTHLY ORAL CHOLECALCIFEROL ON OXIDATIVE STRESS AND INFLAMMATORY MARKERS IN HEMODIALYSIS PATIENTS: A PROSPECTIVE RANDOMIZED TRIAL. M Alshahawey, L ElWakeel, T El Said, N Sabri NEPHROLOGY DIALYSIS TRANSPLANTATION 35, 1891-1891, 2020 | | 2020 |
P1571 WEEKLY VERSUS MONTHLY ORAL CHOLECALCIFEROL ON OXIDATIVE STRESS AND INFLAMMATORY MARKERS IN HEMODIALYSIS PATIENTS: A PROSPECTIVE RANDOMIZED TRIAL. M Alshahawey, L ElWakeel, T El Said, N Sabri Nephrology Dialysis Transplantation, Volume 35, Issue Supplement_3, June …, 2020 | | 2020 |